1. Home
  2. WHD vs ARQT Comparison

WHD vs ARQT Comparison

Compare WHD & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cactus Inc.

WHD

Cactus Inc.

N/A

Current Price

$49.06

Market Cap

3.4B

Sector

Industrials

ML Signal

N/A

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

N/A

Current Price

$24.57

Market Cap

3.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WHD
ARQT
Founded
2011
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.3B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
WHD
ARQT
Price
$49.06
$24.57
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$56.33
$31.86
AVG Volume (30 Days)
1.1M
1.2M
Earning Date
05-29-2026
05-25-2026
Dividend Yield
1.12%
N/A
EPS Growth
18.99
88.79
EPS
0.19
N/A
Revenue
$1,079,051,000.00
$376,072,000.00
Revenue This Year
$42.81
$34.46
Revenue Next Year
$4.93
$29.77
P/E Ratio
$263.16
N/A
Revenue Growth
N/A
91.34
52 Week Low
$33.30
$11.86
52 Week High
$59.25
$31.77

Technical Indicators

Market Signals
Indicator
WHD
ARQT
Relative Strength Index (RSI) 36.77 43.36
Support Level $39.11 $22.26
Resistance Level $59.02 $27.65
Average True Range (ATR) 2.62 1.54
MACD -0.90 -0.18
Stochastic Oscillator 0.47 29.08

Price Performance

Historical Comparison
WHD
ARQT

About WHD Cactus Inc.

Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. It has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: